<DOC>
	<DOCNO>NCT01224613</DOCNO>
	<brief_summary>The purpose study compare immunogenicity reactogenicity self-administered intradermal influenza vaccine ( Intanza ) nurse-administered .</brief_summary>
	<brief_title>Study Compare Self-administered Nurse-administered Intradermal Influenza Vaccine</brief_title>
	<detailed_description>Participants randomize visit one either receive self-administered nurse-administered intradermal influenza vaccine ( Intanza ) . A blood sample take prior vaccination 21 day post-vaccination . Participants record information memory aid 7 day include daily temperature , solicit , unsolicited general reaction . They call study Day 8 collect information . Participants return 21-24 day later follow-up serology review adverse event .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Medically stable person age 1860 Available trial period followup Able read , understand , sign inform consent Able contact telephone followup adverse event Use experimental vaccine within month prior study entry , expect use experimental license vaccine blood/blood product duration study . Receipt immunoglobulin blood product within 3 month prior enrollment Receipt license vaccine within precede 4 week History severe reaction follow influenza vaccination Use cytotoxic therapy biologic modifier previous 2 year . Plans receive cytotoxic therapy study period . Concurrent acute moderate severe illness . ( Vaccination defer recovery . Subjects mild illness fever ≤37.8ºC orally may enrol ) . History medical disorder associate immunosuppression ( eg . include HIVinfected individual , transplant recipient ) History chronic lung , cardiac , renal liver disease , require hospitalization last year . Receipt highdose daily systemic corticosteroid ( inhaled steroid acceptable ) within two week study entry . High dose define dose 20 mg prednisone daily equivalent . Topical steroid allow . Failure give write , informed consent History febrile illness ( &gt; 37.8ºC orally ) within past 72 hour ( immunization may defer ) . Known allergy eggs component vaccine ( i.e. , thimerosal ) History GuillainBarré Syndrome ( GBS )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>